A loop in the N-lobe of human serum transferrin is critical for binding to the transferrin receptor as revealed by mutagenesis, isothermal titration calorimetry, and epitope mapping.
Transferrin (TF) is a bilobal transport protein that acquires ferric iron from the diet and holds it tightly within the cleft of each lobe (thereby preventing its hydrolysis). The iron is delivered to actively dividing cells by receptor mediated endocytosis in which diferric TF preferentially binds to TF receptors (TFRs) on the cell surface and the entire complex is taken into an acidic endosome. A combination of lower pH, a chelator, inorganic anions, and the TFR leads to the efficient release of iron from each lobe. Identification of residues/regions within both TF and TFR required for high affinity binding has been an ongoing goal in the field. In the current study, we created human TF (hTF) mutants to identify a region critical to the interaction with the TFR which also constitutes part of an overlapping epitope for two monoclonal antibodies (mAbs) to the N-lobe, one of which was previously shown to block binding of hTF to the TFR. Four single point mutants, P142A, R143A, K144A, and P145A in the N-lobe, were placed into diferric hTF. Isothermal titration calorimetry (ITC) revealed that three of the four residues (Pro142, Lys144, and Pro145) in this loop are essential to TFR binding. Additionally, Lys144 is common to the recognition of both mAbs which show different sensitivities to the three other residues. Taken together these studies prove that this loop is required for binding of the N-lobe of hTF to the TFR, provide a more precise description of the role of each residue in the loop in the interaction with the TFR, and confirm that the N-lobe is essential to high affinity binding of diferric hTF to TFR.
Mason
Anne B
AB
Department of Biochemistry, College of Medicine, University of Vermont, 89 Beaumont Avenue, Burlington, VT 05405, USA. anne.mason@uvm.edu
Byrne
Shaina L
SL
Everse
Stephen J
SJ
Roberts
Samantha E
SE
Chasteen
N Dennis
ND
Smith
Valerie C
VC
MacGillivray
Ross T A
RT
Kandemir
Banu
B
Bou-Abdallah
Fadi
F
D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry; D001483:Base Sequence; D002151:Calorimetry / Q000379:methods; D006224:Cricetinae; D011992:Endosomes / Q000378:metabolism; D018604:Epitope Mapping; D006639:Histidine / Q000737:chemistry; D006801:Humans; D008969:Molecular Sequence Data; D016296:Mutagenesis; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D011990:Receptors, Transferrin / Q000737:chemistry*; D014168:Transferrin / Q000096:biosynthesis* / Q000737:chemistry*
D000911:Antibodies, Monoclonal; D011990:Receptors, Transferrin; D014168:Transferrin; D006639:Histidine
Science. 1999 Oct 22;286(5440):779-82
10531064
PLoS Biol. 2003 Dec;1(3):E51
14691533
J Biol Inorg Chem. 2009 Jun;14(5):771-81
19290554
Hybridoma. 1991 Oct;10(5):611-23
1725170
Structure. 2005 Nov;13(11):1613-23
16271884
Biochemistry. 2002 Sep 17;41(37):11184-91
12220183
Cell. 1998 Apr 3;93(1):111-23
9546397
Biochem J. 1984 Apr 15;219(2):505-10
6743230
J Biol Chem. 1983 Apr 25;258(8):4715-24
6300098
Protein Expr Purif. 2001 Oct;23(1):142-50
11570856
Mol Cell Proteomics. 2005 Dec;4(12):1959-67
16332734
J Biol Chem. 1994 Mar 11;269(10):7110-4
8125919
Biochemistry. 2005 Jun 7;44(22):8013-21
15924420
Biochim Biophys Acta. 1983 Jul 14;762(4):498-502
6307387
Hybridoma. 1988 Oct;7(5):471-84
2461899
Methods Enzymol. 1983;92:242-53
6855613
FEBS J. 2005 Dec;272(24):6344-53
16336271
Biochemistry. 2006 May 30;45(21):6663-73
16716077
Biochemistry. 2003 Nov 4;42(43):12447-54
14580189
Biochem J. 1997 Aug 15;326 ( Pt 1):77-85
9337853
J Biol Chem. 2006 Aug 25;281(34):24934-44
16793765
Protein Expr Purif. 2004 Aug;36(2):318-26
15249056
Cell. 2004 Feb 20;116(4):565-76
14980223
Biochemistry. 2002 Feb 5;41(5):1647-53
11814359
Biochemistry. 2003 Apr 8;42(13):3701-7
12667060